Straumann highlights digital dentistry strategy, shares on SIX in long-term focus

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 12:44.

Straumann (CH0012280076) underlines its long-term focus on digital dentistry and global expansion in its latest investor materials. The group, whose shares trade on SIX Swiss Exchange and are part of the Swiss Market Index SMI, positions itself as a leading provider of dental implants and orthodontic solutions as reflected in its annual reporting and strategy presentations.Straumann annual report

What Straumann communicates to investors

Straumann’s investor relations page outlines a strategy built around premium dental implants, aesthetic dentistry and clear aligner orthodontics, complemented by practice management software and digital workflows.Straumann investor relations overview The company reports a global footprint across more than 100 countries through subsidiaries and distribution partners, with key markets in Europe, North America and Asia-Pacific, according to its corporate profile.Straumann company profile

The group highlights investment in innovation, including digital planning tools, guided surgery and CAD/CAM prosthetics, to enhance treatment outcomes and efficiency for dentists and clinics, as seen in its product portfolio descriptions.Straumann solutions overview It also stresses training and education for dental professionals via courses and continuing education programs detailed in its education offerings.

Long-term medtech positioning and peers

Straumann positions itself within the global medtech and dental equipment space alongside peers such as Dentsply Sirona and Align Technology, both of which focus on dental devices and orthodontic solutions according to their own investor materials.Align Technology investor page Analysts and market commentators often classify Straumann in the dental implants and aesthetic dentistry niche, distinct from broader orthopedic medtech players like Stryker, which concentrate on orthopedics and surgical instruments.Stryker product announcement

Within the Swiss market, Straumann is viewed as a growth-oriented SMI constituent, with its performance often compared to other Swiss healthcare names such as Roche and Novartis in local market commentary from Swiss financial media.SMI composition overview The company emphasizes recurring demand in dental care, driven by aging populations and higher aesthetic expectations, as a structural tailwind for its business model.

The product behind the stock

One flagship Straumann product line is its dental implant system, built around titanium or ceramic implants, abutments and prosthetic components used to replace missing teeth, as described in its solutions catalog.Straumann implant systems overview The company also offers digital planning tools and clear aligner orthodontic products under brands such as ClearCorrect to support comprehensive treatment workflows.

Where the Straumann shares trade today

The Straumann shares (CH0012280076) trade on SIX Swiss Exchange in Zurich, quoted in Swiss francs. The latest verifiable price information for the shares is provided by SIX and major financial data providers on their live quote pages.

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any form of financial promotion. Figures and dates are based on publicly available sources believed to be reliable. Investors should conduct their own research or consult a qualified advisor before making investment decisions.